Garcia-Chagollan et al. identified a population of CD4+ CD28± NKG2D+ T-cells, which appear to be overrepresented in cervical cancer patients and which express the cytotoxic markers CD107a and CD161 (102). The gene discussed is CD4; the disease is cervical carcinoma.